Advertisement

Essential Blepharospasm and Hemifacial Spasm

  • Ilya LeyngoldEmail author
  • Zachary Berbos
  • Dan Georgescu
  • Richard Lee Anderson
Chapter

Abstract

Benign essential blepharospasm (henceforth “blepharospasm”) and hemifacial spasm are conditions which are linked in the final manifestation of facial spasm and are similar in regard to basic approaches to treatment. These diseases are both movement disorders but have completely different pathophysiology. For this reason, the chapter is divided into separate sections, the first on blepharospasm and the second on hemifacial spasm.

Keywords

Facial Nerve Botulinum Toxin Botulinum Toxin Injection Hemifacial Spasm Orbicularis Muscle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Marsden CD. Blepharospasm: oromandibular dystonia syndrome (Brueghel’s syndrome). A variant of adult-onset torsion dystonia. J Neurol Neurosurg Psychiatry. 1976;39:1204–9.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Talkow J. Klonische krampfe der angelinder: neurotomie der supraorbitalnerven. Klin Montasbl Augenheilkd. 1870;8:129–45.Google Scholar
  3. 3.
    Meige H. Les convulsion de la face une form clinique de convulsion faciale, bilateral et mediane. Rev Neurol (Paris). 1907;10:437–43.Google Scholar
  4. 4.
    Jankovic JJ. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol. 1988;49:103–16.PubMedGoogle Scholar
  5. 5.
    Reynolds DH, Smith JL, Walsh TJ. Differential section of the facial nerve for blepharospasm. Trans Am Acad Ophthalmol Otolaryngol. 1967;71:656–64.PubMedGoogle Scholar
  6. 6.
    Callahan A. Surgical correction of intractable blepharospasm: technical improvements. Am J Ophthalmol. 1965;60:788–91.PubMedGoogle Scholar
  7. 7.
    Weingarten CZ, Putterman AM. Management of patients with essential blepharospasm. Eye Ear Nose Throat Mon. 1976;55:8–24.PubMedGoogle Scholar
  8. 8.
    Henderson JW. Essential blepharospasm. Trans Am Ophthalmol Soc. 1956;54:453–520.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Goldstein JE, Cogan DG. Apraxia of lid opening. Arch Ophthalmol. 1965;73:155–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Lepore FE, Devoisin RC. ‘Apraxia’ of eyelid opening: an involuntary levator inhibition. Neurology. 1985;35:423–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Jordan DR, Anderson RL, Digre KB. Apraxia of lid opening in blepharospasm. Ophthalmic Surg. 1990;21:331–4.PubMedGoogle Scholar
  12. 12.
    Georgescu D, Vagefi MR, McMullan TF, McCann JD, Anderson RL. Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. Am J Ophthalmol. 2008;145(3):541–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg. 1998;14:305–17.PubMedCrossRefGoogle Scholar
  14. 14.
    Jankovic JJ, Patel SC. Blepharospasm associated with brainstem lesions. Neurology. 1983;33:1237–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Aramideh M, Bour LJ, Koelman JH, et al. Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition. Brain. 1994;117:1457–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Hotson JR, Boman DR. Memory-contingent saccades and the substantia nigra postulate for essential blepharospasm. Brain. 1991;114:295–307.PubMedGoogle Scholar
  17. 17.
    Jankovic JJ. Clinical features, differential diagnosis and pathogenesis of blepharospasm and cranial-cervical dystonia. In: Bosniak SL, Smith BC, editors. Advances in ophthalmic plastic and reconstructive surgery, vol. 4. New York: Pergamon Press; 1985. p. 67–82.Google Scholar
  18. 18.
    Creel DJ, Holds JB, Anderson RL. Auditory brain-stem responses in blepharospasm. Electroencephalogr Clin Neurophysiol. 1993;86:138–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Alderson K, Holds JB, Anderson RL. Botulinum-induced alterations of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology. 1991;41:1800–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–70.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Kennedy RA, Stubbs HA. Botulinum-A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103:347–50.PubMedCrossRefGoogle Scholar
  22. 22.
    Adler CH, Factor SA, Brin M, Sethi KD. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Mov Disord. 2002;17(1):158–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Gillum WN, Anderson RL. Blepharospasm surgery: anatomic approach. Arch Ophthalmol. 1981;99:1056–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Jordan DR, Patrinely JR, Anderson RL, et al. Essential blepharospasm and related dystonias. Surv Ophthalmol. 1989;34:123–32.PubMedCrossRefGoogle Scholar
  25. 25.
    McCord CD, Coles WH, Shore JW, et al. Treatment of essential blepharospasm. I. Comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedure. Arch Ophthalmol. 1984;102:266–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Frueh BR, Musch DC, Bersani TA. Effects of eyelid protractor excision for the treatment of benign essential blepharospasm. Am J Ophthalmol. 1992;113:681–6.PubMedGoogle Scholar
  27. 27.
    Patel BCK, Anderson RL. Blepharospasm and related facial movement disorders. Curr Opin Ophthalmol. 1995;5:86–99.CrossRefGoogle Scholar
  28. 28.
    Yen MT, Anderson RL, Small RG. Orbicularis oculi muscle graft augmentation after protractor myectomy in blepharospasm. Ophthal Plast Reconstr Surg. 2003;19:287–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Adler CH, Zimmerman RA, Savino PJ, et al. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol. 1992;32(4):502–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol. 1988;49:151–76.PubMedGoogle Scholar
  31. 31.
    Girard N, Poncet M, Caces F, et al. Three-dimensional MRI of hemifacial spasm with surgical correlation. Neuroradiology. 1997;39(1):46–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg. 1977;47(3):321–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Nielsen VK. Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation. Neurology. 1984;34(4):418–26.PubMedCrossRefGoogle Scholar
  34. 34.
    Nielsen VK. Pathophysiology of hemifacial spasm: II. Lateral spread of the supraorbital nerve reflex. Neurology. 1984;34(4):427–31.PubMedCrossRefGoogle Scholar
  35. 35.
    Nielsen VK, Jannetta PJ. Pathophysiology of hemifacial spasm: III. Effects of facial nerve decompression. Neurology. 1984;34(7):891–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Tan EK, Jankovic J. Hemifacial spasm and hypertension: how strong is the association? Mov Disord. 2000;15(2):363–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21(12):1740–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Ehni G, Woltman HW. Hemifacial spasm: review of one hundred and six cases. Arch Neurol Psychiatry. 1945;53(3):205–11.CrossRefGoogle Scholar
  39. 39.
    Tan EK, Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord. 1999;14(2):345–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol. 2002;59(3):418–20.PubMedCrossRefGoogle Scholar
  41. 41.
    Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP. Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review. Arq Bras Oftalmol. 2006;69(1):23–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Calace P, Cortese G, Piscopo R, et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13(4):331–6.PubMedGoogle Scholar
  43. 43.
    Vartanian AJ, Dayan SH. Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am. 2005;13(1):1–10.PubMedCrossRefGoogle Scholar
  44. 44.
    Eckman PB, Kramer RA, Altrocchi PH. Hemifacial spasm. Arch Neurol. 1971;25(1):81–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Savino PJ, Sergott RC, Bosley TM, Schatz NJ. Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol. 1985;103(9):1305–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Garland PE, Patrinely JR, Anderson RL. Hemifacial spasm. Results of unilateral myectomy. Ophthalmology. 1987;94(3):288–94.PubMedCrossRefGoogle Scholar
  47. 47.
    Tan N, Chan L, Tan E. Hemifacial spasm and involuntary facial movements. QJM. 2002;95(8):493–500.PubMedCrossRefGoogle Scholar
  48. 48.
    Sindou M, Fobé JL, Ciriano D, Fischer C. Hearing prognosis and intraoperative guidance of brainstem auditory evoked potential in microvascular decompression. Laryngoscope. 1992;102(6):678–82.PubMedCrossRefGoogle Scholar
  49. 49.
    Payner TD, Tew JM. Recurrence of hemifacial spasm after microvascular decompression. Neurosurgery. 1996;38(4):686–90; discussion 690–1.PubMedCrossRefGoogle Scholar
  50. 50.
    Han I, Chang JH, Chang JW, Huh R, Chung SS. Unusual causes and presentations of hemifacial spasm. Neurosurgery. 2009;65(1):130–7; discussion 137.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Ilya Leyngold
    • 1
    Email author
  • Zachary Berbos
    • 1
  • Dan Georgescu
    • 2
  • Richard Lee Anderson
    • 1
  1. 1.Center for Facial AppearancesSalt Lake CityUSA
  2. 2.Wilmer Eye InstituteBaltimoreUSA

Personalised recommendations